Loading...
Hepatocellular carcinoma in a gene therapy research subject with ornithine transcarbamylase deficiency
A 66 year old woman who is a manifesting heterozygote for ornithine transcarbamylase deficiency (OTCD) presented with hepatocellular carcinoma (HCC). Fourteen years prior to this presentation she participated in a phase I gene therapy study which used an adenoviral vector, thought to be non-oncogeni...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3273986/ https://ncbi.nlm.nih.gov/pubmed/22129577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2011.10.016 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|